News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
170,681 Results
Type
Article (31811)
Company Profile (11)
Press Release (138859)
Multimedia
Podcasts (4)
Webinars (9)
Section
Business (51915)
Career Advice (364)
Deals (3209)
Drug Delivery (8)
Drug Development (23782)
Employer Resources (32)
FDA (3309)
Job Trends (3167)
News (80207)
Policy (4147)
Tag
2024 Biotech Bay Standard (2)
2024 Pharm Country Standard (1)
2026 Biotech Bay Standard (1)
Academia (2402)
Academic (1)
Accelerated approval (2)
Adcomms (7)
Allergies (19)
Alliances (10821)
ALS (27)
Alzheimer's disease (520)
Antibody-drug conjugate (ADC) (21)
Approvals (3336)
Artificial intelligence (52)
Autoimmune disease (1)
Automation (4)
Bankruptcy (19)
Best Places to Work (2658)
BIOSECURE Act (3)
Biosimilars (8)
Biotechnology (13)
Bladder cancer (19)
Brain cancer (8)
Breast cancer (85)
Cancer (592)
Cardiovascular disease (39)
Career advice (337)
Career pathing (9)
CAR-T (42)
Cell therapy (110)
Cervical cancer (6)
Clinical research (18465)
Collaboration (162)
Compensation (8)
Complete response letters (1)
COVID-19 (1174)
CRISPR (12)
C-suite (144)
Cystic fibrosis (23)
Data (707)
Decentralized trials (1)
Denatured (3)
Depression (6)
Diabetes (54)
Diagnostics (1648)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (23)
Drug pricing (7)
Drug shortages (1)
Duchenne muscular dystrophy (19)
Earnings (6248)
Editorial (4)
Employer branding (2)
Employer resources (29)
Events (17502)
Executive appointments (451)
FDA (3547)
Featured Employer (3)
Frontotemporal dementia (4)
Funding (199)
Gene editing (31)
Generative AI (3)
Gene therapy (74)
GLP-1 (124)
Government (938)
Guidances (3)
Healthcare (5032)
Huntington's disease (2)
IgA nephropathy (7)
Immunology and inflammation (10)
Indications (9)
Infectious disease (1207)
Inflammatory bowel disease (41)
Inflation Reduction Act (1)
Influenza (16)
Intellectual property (16)
Interviews (41)
IPO (1452)
IRA (6)
Job creations (574)
Job search strategy (315)
Kidney cancer (5)
Labor market (6)
Layoffs (32)
Leadership (2)
Legal (677)
Liver cancer (20)
Lung cancer (80)
Lymphoma (46)
Machine learning (2)
Management (9)
Manufacturing (38)
MASH (24)
Medical device (3029)
Medtech (3030)
Mergers & acquisitions (1803)
Metabolic disorders (117)
Multiple sclerosis (18)
NASH (5)
Neurodegenerative disease (24)
Neuropsychiatric disorders (1)
Neuroscience (640)
NextGen: Class of 2025 (1792)
Non-profit (1698)
Northern California (626)
Now hiring (4)
Obesity (39)
Opinion (29)
Ovarian cancer (30)
Pain (15)
Pancreatic cancer (26)
Parkinson's disease (38)
Partnered (4)
Patents (39)
Patient recruitment (33)
Peanut (12)
People (32270)
Phase I (5870)
Phase II (8460)
Phase III (5619)
Pipeline (181)
Policy (19)
Postmarket research (955)
Preclinical (3051)
Press Release (25)
Prostate cancer (27)
Psychedelics (8)
Radiopharmaceuticals (66)
Rare diseases (87)
Real estate (1271)
Recruiting (15)
Regulatory (2950)
Reports (3)
Research institute (1354)
Resumes & cover letters (23)
Rett syndrome (2)
RNA editing (1)
RSV (1)
Schizophrenia (9)
Series A (30)
Series B (19)
Sickle cell disease (16)
Southern California (483)
Spinal muscular atrophy (38)
Sponsored (6)
Startups (1102)
Stomach cancer (1)
Tariffs (3)
The Weekly (1)
United States (4750)
Vaccines (201)
Venture capitalists (1)
Weight loss (22)
Women's health (6)
Worklife (2)
Date
Today (31)
Last 7 days (150)
Last 30 days (566)
Last 365 days (6971)
2025 (2027)
2024 (7448)
2023 (9216)
2022 (11465)
2021 (13198)
2020 (12731)
2019 (12102)
2018 (8984)
2017 (8678)
2016 (8864)
2015 (10194)
2014 (7787)
2013 (7567)
2012 (7526)
2011 (7536)
2010 (6763)
Location
Africa (263)
Alabama (11)
Alaska (3)
Arizona (38)
Arkansas (6)
Asia (10374)
Australia (2605)
California (1306)
Canada (409)
China (96)
Colorado (59)
Connecticut (63)
Delaware (27)
Europe (27520)
Florida (158)
Georgia (48)
Idaho (12)
Illinois (121)
India (3)
Indiana (61)
Iowa (2)
Japan (48)
Kansas (13)
Kentucky (4)
Louisiana (1)
Maine (13)
Maryland (144)
Massachusetts (837)
Michigan (38)
Minnesota (67)
Mississippi (1)
Missouri (20)
Montana (6)
Nebraska (4)
Nevada (11)
New Hampshire (8)
New Jersey (372)
New Mexico (8)
New York (385)
North Carolina (259)
North Dakota (2)
Northern California (626)
Ohio (66)
Oklahoma (5)
Oregon (9)
Pennsylvania (255)
Puerto Rico (1)
Rhode Island (11)
South America (288)
South Carolina (3)
Southern California (483)
Tennessee (25)
Texas (191)
Utah (41)
Virginia (34)
Washington D.C. (17)
Washington State (135)
West Virginia (1)
Wisconsin (10)
170,681 Results for "emory university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioCardia Initiates Patient Enrollment at Emory University School of Medicine for Ongoing CardiAMP HF II Pivotal Study
April 11, 2025
·
7 min read
Lone Star Bio
InGeneron Announces Encouraging Results from Emory University’s 480-Patient Phase III Knee Osteoarthritis Trial
InGeneron, Inc., a clinical stage biotechnology company, announces the publication of a Phase III 480-patient clinical trial sponsored by Emory University (Atlanta, GA, USA).
November 3, 2023
·
6 min read
Bridge Biotherapeutics Launches a Research Collaboration with Emory University School of Medicine to Explore Combination Therapy of BBT-877 for KRAS/P53 Mutant NSCLC Patients Resistant to Anti-PD-1 Blockade
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen’s Lab at Emory University School of Medicine.
March 28, 2024
·
4 min read
Press Releases
TFF Pharmaceuticals Partners with Emory University and BARDA to Develop a Dry Powder Inhaled mRNA-based Treatment for Influenza and COVID
September 11, 2024
·
5 min read
Business
Spineology® Appoints new Member to Leadership Team; Spine Veteran Emory Rooney joins as Executive Vice President of Sales
Spineology ® Appoints new Member to Leadership Team; Spine Veteran Emory Rooney joins as Executive Vice President of Sales.
April 4, 2024
·
2 min read
Press Releases
Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System
August 1, 2024
·
4 min read
Business
Align Technology Appoints Emory Wright, EVP Direct Fabrication Manufacturing Platform to Build the Company’s Next Generation Manufacturing Operations -- Wright Plans to Retire in 2026
Align Technology, Inc. today announced it has appointed Emory Wright, executive vice president, direct fabrication manufacturing platform, effective immediately.
May 22, 2024
·
5 min read
Business
Ravi I. Thadhani, MD, MPH, appointed Executive Vice President for Health Affairs at Emory University
Following an extensive international search, Emory University announced that Ravi I. Thadhani, MD, MPH, has been appointed executive vice president for health affairs.
October 27, 2022
·
5 min read
BioMidwest
Chemical Insights Research Institute and Emory University’s Rollins School of Public Health Team to Study the Human Health Impact of PFAS Chemical Exposure
Chemical Insights Research Institute of UL Research Institutes and Emory University’s Rollins School of Public Health have announced upcoming research to study human exposure to per- and polyfluoroalkyl substances.
February 21, 2023
·
5 min read
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
1 of 17,069
Next
